SRSF2 mutations are found in ~50% of chronic myelomonocytic leukemia (CMML), ~20% of MDS, and ~15% of AML patients and ~3–5% of healthy individuals with clonal hematopoiesis (CH). The gene discussed is SRSF2; the disease is acute myeloid leukemia.